Targeting of the Adenosine Receptors as a Novel Strategy for the Treatment of Arterial Hypertension

Journal of Neurology & Neurophysiology
doi 10.4172/2155-9562.1000243
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Adenosine Receptors as Drug Targets for Treatment of Pulmonary Arterial Hypertension

Frontiers in Pharmacology
Pharmacology
2017English

Potential of Proteinase-Activated Receptors as a Novel Target for Treatment of Pulmonary Hypertension

Folia Pharmacologica Japonica
Pharmacology
2014English

Targeting Proteasome-Associated Deubiquitinases as a Novel Strategy for the Treatment of Estrogen Receptor-Positive Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2018English

Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Medical Council
2016English

Targeting Histones for Degradation in Cancer Cells as a Novel Strategy in Cancer Treatment

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2018English

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2016English

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2014English

Targeting the Metabolism of Leukemia Stem Cells as a Novel Therapeutic Strategy

Drugs in Context
Molecular MedicinePharmacology
2013English

Nebivolol in the Treatment of Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy